Basal insulin secretion capacity predicts the initial response and maximum levels of beta-hydroxybutyrate during therapy with the sodium-glucose co-transporter-2 inhibitor tofogliflozin, in relation to weight loss
| Image |  |
|---|---|
| Description | scientific article published on 14 November 2019 |
| Author/s |
author: Yuichi Sato Kohei Kaku Alkihiro Yoshida Kiyohide Nunoi Hideki Suganami |
| Publication date | November 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |